LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Combined Therapeutics

Combined Therapeutics (CTx) is a pre-clinical-stage biotech in the game-changing segment of cancer research that is immunotherapy. The company is converging nanomedicine and biotechnology to enhance the tumoral cells and the tumoral microenvironment targeting.

  • Romain Micol, MD, MPH, MBA, PhD President, CEO, Co-Founder
  • Robert Langer, PhD Co-Founder, MIT Institute Professor
  • Dan Anderson, PhD Co-Founder, MIT Professor
  • John Vaillancourt CFO
  • Hao Yin Liver Immunology Specialist